Stocks Overview

LAST PRICE
2.6900
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
2.5700/ 2
Ask / Lots
2.9800/ 5
Open / Previous Close
2.6700 / 2.6900
Day Range
Low 2.6200
High 2.7700
52 Week Range
Low 0.3599
High 6.0400
Volume
373,864
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 2.65
Time	Volume	ADCT
09:32 ET	4755	2.74
09:41 ET	100	2.71
09:43 ET	508	2.67
09:45 ET	1263	2.65
09:48 ET	500	2.66
09:50 ET	400	2.65
09:52 ET	1392	2.62
09:54 ET	2735	2.65
09:57 ET	200	2.67
09:59 ET	2052	2.6965
10:01 ET	2990	2.71
10:03 ET	4000	2.72
10:06 ET	1000	2.72
10:08 ET	1715	2.72
10:10 ET	6295	2.71
10:12 ET	3308	2.725
10:14 ET	1400	2.74
10:15 ET	300	2.75
10:19 ET	6777	2.77
10:21 ET	300	2.76
10:26 ET	100	2.76
10:28 ET	721	2.74
10:30 ET	683	2.73
10:32 ET	3120	2.73
10:33 ET	300	2.74
10:35 ET	400	2.73
10:42 ET	100	2.71
10:46 ET	500	2.7283
10:48 ET	1217	2.76
10:50 ET	619	2.74
10:51 ET	200	2.73
10:57 ET	1233	2.74
11:00 ET	100	2.735
11:02 ET	636	2.73
11:04 ET	1084	2.75
11:06 ET	800	2.73
11:08 ET	500	2.725
11:09 ET	447	2.73
11:11 ET	300	2.72
11:13 ET	1811	2.74
11:15 ET	100	2.735
11:18 ET	601	2.73
11:20 ET	2165	2.7443
11:24 ET	1904	2.725
11:27 ET	100	2.725
11:29 ET	1726	2.75
11:31 ET	300	2.74
11:36 ET	700	2.74
11:38 ET	18712	2.7
11:40 ET	1800	2.7
11:42 ET	4410	2.74
11:44 ET	940	2.74
11:45 ET	200	2.73
11:47 ET	1756	2.7
11:51 ET	1000	2.68
11:54 ET	4061	2.69
11:58 ET	100	2.695
12:00 ET	2718	2.695
12:02 ET	200	2.695
12:03 ET	300	2.69
12:05 ET	1764	2.69
12:07 ET	200	2.69
12:09 ET	901	2.685
12:12 ET	200	2.685
12:14 ET	1310	2.69
12:16 ET	800	2.685
12:18 ET	700	2.68
12:20 ET	700	2.67
12:21 ET	100	2.675
12:23 ET	1862	2.67
12:25 ET	100	2.67
12:27 ET	100	2.67
12:30 ET	400	2.67
12:32 ET	1100	2.665
12:34 ET	500	2.665
12:36 ET	1592	2.675
12:38 ET	400	2.675
12:39 ET	100	2.67
12:41 ET	100	2.67
12:43 ET	503	2.67
12:45 ET	600	2.665
12:48 ET	1675	2.65
12:50 ET	700	2.65
12:52 ET	3296	2.65
12:56 ET	496	2.65
12:59 ET	300	2.6411
01:03 ET	122	2.64
01:06 ET	400	2.64
01:08 ET	818	2.645
01:10 ET	100	2.645
01:12 ET	6767	2.645
01:15 ET	300	2.64
01:19 ET	100	2.645
01:21 ET	1217	2.645
01:24 ET	1000	2.645
01:26 ET	7385	2.66
01:28 ET	600	2.66
01:30 ET	200	2.66
01:33 ET	1882	2.66
01:35 ET	1501	2.655
01:37 ET	3313	2.68
01:42 ET	183	2.69
01:44 ET	100	2.7
01:48 ET	300	2.68
01:50 ET	782	2.69
01:51 ET	100	2.7
01:53 ET	100	2.69
01:55 ET	4375	2.7
01:57 ET	1915	2.69
02:02 ET	100	2.685
02:08 ET	4706	2.665
02:09 ET	3952	2.675
02:11 ET	2944	2.685
02:13 ET	500	2.685
02:18 ET	500	2.68
02:20 ET	200	2.68
02:22 ET	400	2.685
02:24 ET	1700	2.705
02:26 ET	100	2.7
02:27 ET	1017	2.7
02:29 ET	2070	2.71
02:33 ET	100	2.71
02:36 ET	400	2.71
02:38 ET	380	2.7
02:40 ET	300	2.705
02:42 ET	1800	2.7
02:44 ET	200	2.7
02:45 ET	190	2.7005
02:47 ET	249	2.705
02:49 ET	3474	2.73
02:51 ET	36855	2.7
02:54 ET	2291	2.685
02:56 ET	3500	2.67
02:58 ET	8480	2.69
03:00 ET	908	2.67
03:02 ET	603	2.67
03:03 ET	4755	2.67
03:05 ET	3777	2.7
03:09 ET	400	2.71
03:12 ET	600	2.7185
03:14 ET	100	2.72
03:16 ET	699	2.7
03:18 ET	200	2.705
03:20 ET	100	2.71
03:21 ET	3404	2.71
03:27 ET	3091	2.72
03:30 ET	1211	2.72
03:32 ET	2753	2.72
03:34 ET	300	2.72
03:36 ET	1000	2.715
03:38 ET	4161	2.71
03:39 ET	4259	2.7
03:41 ET	100	2.705
03:43 ET	1200	2.705
03:45 ET	500	2.7
03:48 ET	4479	2.69
03:50 ET	615	2.695
03:52 ET	2953	2.695
03:54 ET	2323	2.7
03:56 ET	5801	2.7
03:57 ET	10880	2.705
03:59 ET	10788	2.69

Data delayed at least 15 minutes.

Jun 3, 2024
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan, from 4:05PM ET on Monday Jun 03, 2024 by Dow Jones
  4:05PM ET on Monday Jun 03, 2024 by Dow Jones
May 30, 2024
- DJ ADC Therapeutics Initiated at Overweight by Cantor Fitzgerald, from 9:06AM ET on Thursday May 30, 2024 by Dow Jones
  9:06AM ET on Thursday May 30, 2024 by Dow Jones
- ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference, from 7:15AM ET on Thursday May 30, 2024 by Dow Jones
  7:15AM ET on Thursday May 30, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesADCT ADC Therapeutics SA	254.9M	-1.0x	---
United StatesPSTX Poseida Therapeutics Inc	269.5M	-2.3x	---
United StatesCDXS Codexis Inc	207.4M	-3.2x	---
United StatesENTA Enanta Pharmaceuticals Inc	252.7M	-2.0x	---
United StatesADAP Adaptimmune Therapeutics PLC	227.5M	-1.2x	---
United StatesMGNX MacroGenics Inc	273.7M	-12.0x	---
As of 2024-06-25

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Contact Information

Headquarters: Biopole, route de la Corniche 3BEPALINGES, Switzerland 1066
Phone: ---
Fax: ---

Executives

Non-Executive Chairman of the Board: Ron Squarer
Chief Executive Officer, Director: Ameet Mallik
Chief Financial Officer: Jose Carmona
Chief Scientific Officer: Patrick Van Berkel
Chief Legal Officer: Peter Graham

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$254.9M
Revenue (TTM)	$68.6M
Shares Outstanding	96.2M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.57
EPS	$-2.77
Book Value	$-1.80
P/E Ratio	-1.0x
Price/Sales (TTM)	3.7
Price/Cash Flow (TTM)	---
Operating Margin	-216.68%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

ADC Therapeutics SA
NYSE:ADCTUnited States

Search Criteria

Charts

Recent News

Jun 3, 2024

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan, from 4:05PM ET on Monday Jun 03, 2024 by Dow Jones

May 30, 2024

DJ ADC Therapeutics Initiated at Overweight by Cantor Fitzgerald, from 9:06AM ET on Thursday May 30, 2024 by Dow Jones

ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference, from 7:15AM ET on Thursday May 30, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar